好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

History of Fetal Neurology (Past, Current, Future)
History of Neurology
P4 - Poster Session 4 (5:00 PM-6:00 PM)
11-005
Describe the historical progress in fetal neurology.

Fetal neurology is a rapidly evolving subspecialty within child neurology. The discoveries are as early as the 16th century and enhance the understanding of the developing central nervous system and its evolution for comprehensive counseling and management of prospective parents facing an in-utero diagnosis. This abstract highlights the evolution of the field and the key technological milestones that have advanced this subspecialty.

Our research delved into the historical literature from 1900-2024, using reputable databases like PubMed and JSTOR. Our analysis focused on identifying thematic trends, methodological advancements, and milestone key findings, providing a comprehensive understanding of the evolution of fetal neurology.

Ian Donald and his colleagues introduced ultrasound in 1956, revolutionizing prenatal diagnostics. Ultrasound enabled physicians to visualize fetal brain structures in real-time. Raymond Damadian later discovered Magnetic Resonance Imaging (MRI) in the late 1970s. The use of MRI in fetal diagnostics was approved in 1982, providing high-resolution images of the fetal brain and enhancing comprehensive prognostic counseling and management.

Today, we have seen progress in understanding fetal neurological development's, molecular, and genetic aspects. From the ability to do amniocentesis in the 1960s to non-invasive prenatal testing in 2012, followed by whole genome sequencing in 2020, advances in genetic technology, including the discovery of genes associated with early-onset neurological disorders, have expanded the knowledge of prenatal risk factors and pathways involved in fetal brain development. 

Technological advancements have been a driving force behind these improvements, empowering neurologists to utilize imaging and genetic data more effectively. The integration of telemedicine has improved access to this specialized service, offering greater support to patients and enhancing consultation and providing prognostic considerations. The future holds even greater promise, with the potential for profound impacts on early diagnosis, therapeutics, ethical considerations, and in-utero interventions for improved neurological outcomes.

Authors/Disclosures
Michael M. Chadehumbe
PRESENTER
Mr. Chadehumbe has nothing to disclose.
Alison L. Christy, MD, PhD, FAAN Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Dawn L. Gano, MD (BC Children's Hospital and UBC) The institution of Dr. Gano has received research support from Cerebral Palsy Alliance Research Foundation. The institution of Dr. Gano has received research support from NIH.
Sonika Agarwal, MD, FAAN Dr. Agarwal has nothing to disclose.